Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc.

NASDAQ:CRDL

Overview | Financials
Company Name Cardiol Therapeutics Inc.
Symbol CRDL
Currency USD
Price 1.25
Market Cap 102,004,250
Dividend Yield 0%
52-week-range 0.96 - 3.12
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. David G. Elsley MBA
Website https://www.cardiolrx.com

An error occurred while fetching data.

About Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx

Related Stocks

Genprex, Inc. logo

Genprex, Inc.

GNPX

0.738 USD

Merrimack Pharmaceuticals, Inc. logo

Merrimack Pharmaceuticals, Inc.

MACK

15.145 USD

Sientra, Inc. logo

Sientra, Inc.

SIEN

0.174 USD

TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

TCRX

2.63 USD

IceCure Medical Ltd logo

IceCure Medical Ltd

ICCM

1.24 USD

Harpoon Therapeutics, Inc. logo

Harpoon Therapeutics, Inc.

HARP

23.01 USD

Anebulo Pharmaceuticals, Inc. logo

Anebulo Pharmaceuticals, Inc.

ANEB

1.596 USD

HCW Biologics Inc. logo

HCW Biologics Inc.

HCWB

0.342 USD

Financials

Numbers are in millions USD

Numbers are in millions USD